Clinical trials are essential for advancing cancer treatments, but they require a high level of trust from participants. Patients must believe that the trial is ethical, that their safety is a priority, and that the potential benefits outweigh the risks. Transparent communication about the trial's purpose, procedures, and potential outcomes is crucial for gaining and maintaining this trust.
